FDAnews
www.fdanews.com/articles/172211-boston-scientific-begins-study-evaluating-resorbable-drug-eluting-scaffold-system

Boston Scientific Begins Study Evaluating Resorbable, Drug-Eluting Scaffold System

July 20, 2015

Boston Scientific has enrolled its first patient in a clinical trial evaluating its resorbable, drug-eluting scaffold system, the Marlborough, Mass., devicemaker said Monday.

The single arm study, which will eventually enroll up to 30 patients, is assessing the device’s safety and efficacy in treating atherosclerotic coronary lesions.

Boston Scientific’s scaffold technology is in development and not available for sale.

In the U.S. and Japan, the Synergy stent is designated for investigational use only, while in Europe the product is CE Mark certified and commercially available. — Jason Scott